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Abstract 
 Mucosal barriers encounter an environment that is rich in pathogens that possess mechanisms 
for invading mucosal tissues. These barriers also encounter innocuous antigens, such as foods, 
airborne antigens, and microbiota. The mucosa has developed a sophisticated immune system 
that can mount robust immune responses against pathogenic antigens, while maintaining 
mucosal tolerance against non-pathogenic antigens. Accumulating evidence indicates that the 
mucosal epithelium, dendritic cells, and a subtype of T cells with regulatory properties play 
important roles in the development and maintenance of mucosal tolerance. Moreover, the 
micribiota also contribute to regulating the mucosal immune system. A failure to develop or the 
breakdown of mucosal tolerance can result in allergic diseases, such as food allergy and asthma. 
By taking advantage of the unique characteristics of the mucosal immune system, strategies that 
induce  regulatory cells in vivo and, thereby, reconstitute mucosal tolerance may be used to 
develop novel therapies that are suitable for treating or preventing of allergic diseases.
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Introduction 
 Because most pathogens enter the body through mucosal surfaces, mucosal immune 
responses are required to ward off infection. These mucosal surfaces are colonized by vast 
numbers of microbes, collectively referred to as the microbiota. The microbiota has been found 
to have profound effects on a host's immune system without provoking deleterious immune 
responses'. In addition, mucosal surfaces are exposed to a wide variety of innocuous 
environmental antigens, such as food in the intestine and aeroantigens in the respiratory tracts. 
These innocuous antigens can induce immune tolerance or hyporesponsiveness rather than 
active immunity. 
 Mucosal tolerance prevents harmful inflammatory responses, for example to food antigens, 
and plays a role in establishing homeostasis between the microbiota and the host at mucosal 
membranes. Thus, mucosal tolerance is not merely a lack of immune response; rather, it is a 
specific immunological response. A failure to develop or the breakdown of oral tolerance can 
result in food  allergy. This review ill describe r cent findings that have contributed o our 
understanding of the s mechanisms of oral tolerance and the pathophysiology of food allergy.
Oral tolerance is primarily mediated by regulatory T cells.
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 In healthy adults, certain food proteins can be detected in the blood soon after eating3. These 
ingested food proteins are not always ignored by the immune system, because food antigen can 
simultaneously induce the expression of an activation marker, CD69, and behavioral changes in 
T cells in both local and peripheral ymphoid tissues, depending on the antigen doses4'  5.
 Weiner et al.6 demonstrated that the dose of a fed antigen affected the mechanism underlying 
oral tolerance induction. Repeated exposure to low doses of antigen induced active suppression 
by several subsets of regulatory T cells (Tregs), whereas exposure to high antigen doses resulted 
in clonal deletion and/or anergy. We previously showed that active suppression by Tregs and 
clonal deletion and/or anergy were not mutually exclusive and that they may occur 
simultaneously after oral tolerance induction in Ag-specific T cell receptor transgenic  mice'. 
 Using an adoptive transfer system of Ag-specific T cells, however, it has been demonstrated 
that  Foxp3+ Tregs could be induced de novo from conventional naive  CD25-CD4+ T cells after 
tolerogenic Ag administration via the oral route in a dose-dependent  fashion8. Moreover, there 
is little direct evidence that clonal deletion and/or anergy contributes to oral tolerance in the 
presence of a polyclonal T-cell repertoire. These findings suggest hat Tregs play a pivotal role 
in the development of oral tolerance. 
 A number of different Tregs have been implicated in oral tolerance, including 
 IL-10-producing T-regulatory type 1 cells  (Trl cells) and  TGF-P-producing Th3 T cells, in
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addition to  Foxp3+ Tregs. Two main types of  Foxp3+ Tregs have been identified. Natural Tregs 
(nTregs) are selected in the thymus as a consequence of their reactivity to self, whereas induced 
or adaptive Tregs (iTregs or aTregs) develop in the peripheral immune system under various 
conditions9. Induction of the  Foxp3+ peripherally derived Tregs (pTregs) from  naïve T cells 
requires  TGF-I3, which is produced by various cell types, including Th3  CD4+ T cells. Although 
nTregs, also referred to as thymus-derived Treg cells (tTregs), are stable in vivo, iTregs can 
differentiate into other types of effector T cells under inflammatory  conditions1°. In a mouse 
model in which iTregs but not nTregs could be generated, oral tolerance could not be induced, 
suggesting that iTregs were essential for the development of oral  tolerance1°'11. 
 The common characteristics of Tregs are their expression of one or more anti-inflammatory 
cytokines, such as  IL-10, TGF-13, or IL-35, and/or inhibitory surface molecules, such as 
cytotoxic T-lymphocyte antigen 4 (CTLA4), lymphocyte-activation gene-3 (LAG-3), 
glucocorticoid-induced tumor necrosis factor receptor (GITR), CD39, CD73, or Nrp-1 
(neurophilin  1)12-15. 
 Oral tolerance is abolished in lymphotoxin-deficient mice that lack both lymph nodes and 
Peyer's patches (PPs), but can be readily induced in mice without PPs but with mesenteric 
lymph nodes  (MLNs)16. The initiation of oral tolerance is impeded by mesenteric 
 lymphadenectomy17. MLNs appear to be critical for inducing oral tolerance.
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 In contrast, it has been shown that injecting antigen directly into the portal vein that drains 
blood from the intestine to the liver induces antigen-specific  tolerance18. Conversely, diverting 
the blood flow away from the liver by portocaval shunting prevents the induction of oral 
 tolerance19'  20,indicating the inherent olerogenicity of the liver. Kupffer cells, conventional 
liver dendritic ells (DCs), and liver sinusoidal endothelial cells, which efficiently sample 
circulating antigen and act as non-professional antigen-presenting cells, have been shown to 
induce tolerance rather than active  immunity18. Moreover, plasmacytoid DCs (pDCs), which 
have been implicated in inducing systemic tolerance, are particularly abundant in the liver21. 
The relative contributions ofMLNs, the liver, and other sites to oral tolerance induction remain 
unknown (Figure). 
 A fraction of Tregs that expand in the lamina propria (LP) may exit this tissue and enter the 
circulation either via the draining lymphatics, or directly via the bloodstream. Those iTregs that 
emigrate from the LP may act more generally, either by directly inhibiting systemic effector T
cells or by promoting the generation of additional iTregs in systemic tissues by a process of 
infectious tolerance. 
Intestinal dendritic cells organize induction and expansion of iTregs 
 Two types of conventional  CD11c+DCs (cDCs), such as  CD103(aE(37)+DCs and
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 CD103-CX3CR1+ DCs have been identified in the LP (2). Mucosal DCs can capture antigen 
through at least four different routes.  CD103-CX3CR1+ DCs directly sample antigens by 
extending transepithelial dendrites between enterocytes.  CD103±DCs can capture antigens that 
are transported by paracellular diffusion across enterocytes that line the intestinal villus, either 
by a transcellular t ansport mechanism, transcytosis by microfold cells (M cells), or by 
goblet-cell-associated antigen passage22. To a certain extent, he routes of uptake depend on the 
nature of the particular antigen. Orally administered inert particles or nonpathogenic bacteria 
appear to preferentially enter into gut associated lymphoid tissue (GALT) by M-cell-mediated 
transcytosis, whereas oluble antigens are taken up by DCs in the LP and, to a lesser extent, the 
GALT23. Antigenic material may also reach the LP within exosomes, which are formed by 
fusing major histocompatibility complex class II loading compartments with endosomes that 
contain only partially degraded proteins in enterocytes23. 
 The differentiation f  CD103+DCs depends upon retinoic acid (RA) and  TGF-I3 produced by 
intestinal epithelial cells24. After acquiring antigen,  CD103±DCs migrate from the LP to the 
MLNs in a CCR7-dependent manner25.  CD103±DCs express the enzyme retinaldehyde 
dehydrogenase (RALDH) 2, which converts the vitamin A metabolite r tinal to RA. In concert 
with  TGF-13, which is also produced by  CD103±DCs and is activated by the integrin  avr38 on 
these DCs, RA can promote the differentiation of  naïve T cells within the NLNs into  Foxp3+
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 iTregs14,  26-29.  CD103±DCs use RA to imprint  naïve T cells with the gut homing markers integrin 
 a4137 and chemokine receptor CCR9. Further contributing to their tolerogenic capabilities, 
 CD103+DCs also express the enzyme indoleamine 2,3-dioxygenase (IDO), which inhibits the 
generation of T-effector cells by metabolizing tryptophan to  kynurenine30. Inhibition of IDO 
was shown to abrogate the development of  Foxp3+iTregs in vitro and prevent he development 
of oral tolerance in vivo31. Removing vitamin A and/or tryptophan from the diet also hinders the 
tolerogenic effects of  CD103±DC by reducing their ability to induce iTregs and imprint gut 
homing receptors on  lymphocytes30. Thus,  CD103+DCs are essential for oral tolerance 
induction. 
 In contrast,  CD103-CX3CR1+CD11c+DCs are functionally closer to macrophages than they 
are to cDCs, as they do not migrate from the LP to MLNs and cannot present antigen to  naïve T 
cells under steady state conditions32.  CD103-CX3CR1+ cells are efficient at sampling antigens 
by extending transepithelical dendrites and passing these antigens to neighboring migratory 
 CD103+DCs for subsequent ransport and presentation23.  CD103-CX3CR1+ cells have been 
shown to produce  IL-10 and locally facilitate the expansion of  Foxp3+ iTregs in the  LP33. 
 CD103-CX3CR1+ cells are necessary for maintaining local tolerance induction, as tolerance is 
abrogated in CXCR1-deficient  mice33. 
 The transepithelial dendrites extended by CX3CR1 + cells in the LP have been shown to
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interact with bacteria in the lumen; thus, they may also play a specific role in inducing tolerance 
to commensal bacteria. Recently,  CX3CR1+CD1  lb+CD1  c+ cells were further subdivided into 
two subsets based on their expression levels of CX3CR134.  CX3CR1intCD1  lb+CD1  c+ cells 
could promote the development of Th17 cells, whereas CX3CR1 highCD1 lb+CD1 c+ cells 
suppressed  CD4+ T-cell proliferation i  a cell—cell contact-dependent manner, and contributed 
to preventing intestinal inflammation. 
 pDCs can produce high levels of type I interferons, and can also activate  Foxp3+ iTreg as well 
as  IL10+  Trl cells. A substantial proportion of MLN DCs produce CCL22, which attracts iTregs 
via CCR4, and are located in juxtaposition to iTregs35. The interaction with iTregs via 
CTLA-4/B7 may make DCs constitutively express functional IDO. Mice that were genetically 
deficient in CCR4 showed markedly reduced IDO expression i mesenteric lymph node DCs.
Intestinal mucosa and mesenteric lymph nodes engender a tolerogenic milieu 
The acquisition of the unique tolerogenic properties of  CD103+DCs likely requires a specific 
milieu of local conditioning factors provided by intestinal epithelial cells (IECs), commensal 
bacteria, and dietary constituents. IEC—derived factors may include TGF-13, RA,  IL-10, 
vasoactive intestinal peptide (VIP), thymic stromal lymphopoetin (TSLP), and hepatocyte 
growth factor (HGF)  24,  36-38. The sources of RA in the intestine may include RA produced by
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epithelial cells, which metabolize retinoids taken up from the diet39. Intestinal epithelial 
cell-derived RA induces DCs to express RALDH, and thereby intestinal DCs are capable of 
metabolizing food-derived vitamin A to produce RA by themselves38. Independent of 
tolerogenic DCs, epithelial cells express MHC class II molecules, but not conventional 
co-stimulatory molecules; thus, that they may act as nonprofessional APCs to induce T cell 
anergy49. 
 Stromal cells from mesenteric lymph nodes also express higher levels of RA-producing 
enzymes than do peripheral lymph node stromal  cells'''. Stromal cells from mesenteric lymph 
nodes, but not from skin-draining lymph nodes, support the generation of  Foxp3+ Tregs. This 
suggests that tissue-specific differences in stroma may also aid in generating a uniquely 
tolerogenic milieu. 
 CD8+ T cells and  y8 T cells also function as regulatory cells in mucosal immunity. 
 Accumulating evidence has shown that subsets of  CD8+ T-cells function as regulatory cells 
either directly by killing immune cells or indirectly by coopting other cells to produce 
suppressive molecules, such as  TGF-13 and  IL-1042'  43. Although LP  CD8+ T cells and 
intestinal epithelial cell—activated  CD103±CD8+ T cells exhibit regulatory activities in vitro and, 
thus, might play an active role in oral  tolerance"'  45, the role of these  CD8+ T cells in controlling
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allergic reactions in the gastrointestinal mucosa remains uncertain. We have demonstrated that 
systemic immunization with allergen induced  regulatory  CD8+ T cells that could inhibit the 
development of allergic diarrhea and that these  CD8+ T cells may have exerted a regulatory 
function through both  IL-10-dependent and -independent mechanisms46. These findings suggest 
the possibility that manipulating  CD8+ regulatory T cells may expand our therapeutic strategies 
for food allergy. 
 In a food allergy mouse model,  y6 TCR blockade prior to inducing sensitization resulted in 
higher antigen-specific IgE levels and incrased mast cell degranulation. These findings suggest 
a regulatory role for  yo T cells in the development of allergic  sensitization'''. A possible role for 
natural killer T (NKT) cells in oral tolerance is controversial and the outcomes may depend on 
the experimental models used. NKT cell-deficient mice showed impaired oral tolerance due to a 
failure to induce  IL-10 and  TFG-I3 producing  CD25+CD4+ Tregs48. Oral tolerance was normally 
induced in  Ja2814- mice that lacked  Va  14+ NKT cells, suggesting that NKT cells are 
dispensable for inducing oral  tolerance49.
Regulatory B cells can induce Tregs. 
Emerging evidence suggests that regulatory types of B cells (Bregs) that are generated under 
inflammatory conditions are capable of inducing tolerance. Bregs may comprise several
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subpopulations that exhibit different mechanisms of immunomodulation, i cluding the 
production of anti-inflammatory cytokines  (IL-10 or  TGF-(31), functioning as inhibitory antigen 
presenting cells, and inducing or recruiting  Tregs50. Mouse  IL-10-producing B cells (designated 
 B10 cells) display the  CD1dhiCD5+CD19hi p enotype and suppress allergic inflammation 
through their induction of iTreg cells51. B cells isolated from Peyer's patches can generate 
iTregs that express CTLA4, ICOS,  OX40,  PD-1, and TNF-RII, and produce lower amounts of 
IL-2 and higher amounts of  IL-1052. B cells in Peyer's patches may play an important role in 
oral tolerance as regulatory cells. 
 In humans,  B10 cells have been identified within the  CD24h1CD27+ B cell compartment and 
negatively regulate monocyte cytokine production in an  IL-10-dependent manner53. Although 
 B10 cells represent a small fraction of blood B cells in healthy subjects, they are increased in the 
blood of patients with inflammatory disorders53. Recent evidence has implicated regulatory B
cells in the development of tolerance to food allergens in humans; however, it remains unknown 
how these cells are related to human  B10 cells54' 55.
IgA protects against sensitization or triggering of allergic reactions by oral antigens. 
 Foxp3'CD4' Treg cells in Peyer's patches can differentiate into follicular B helper T cells 
(TFH cells), which then participate in immunoglobulin A responses against intestinal  antigens56.
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Secretary IgA (sIgA), a prototypic mucosal immunoglobulin, prevents the uptake of antigens 
from the gut lumen and also secrets back out antigens that have penetrated the epithelial barrier 
into the lumen by forming sIgA-antigen complexes. IgA deficiency in children has been 
reported to be associated with an increased frequency of food allergy57. Thus, IgA has been 
hypothesized to play a protective role in the context of food allergy. 
 However, Strait et  al. found that systemic transfer of antigen-specific IgA was also protective 
against anaphylaxis that was triggered by the oral route58. However, this was not dependent on 
IgA secretion into the lumen, and IgA had no protective ffect when it was administered in 
conjunction with the antigen intraluminally, suggesting that IgA has protective ffects at the 
systemic level but do not rule out a protective role for IgA at the mucosal surface. 
 In contrast to the immune xclusion by sIgA, sIgA-antigen complexes are transported by M 
cells from the intestinal lumen to subepithelial DCs, which recognize and internalize these 
complexes through the C-type lectin DC-SIGN on DCs59. Antigen presented inconjunction with 
IgA generates a different type of immune response than that when antigen is presented alone. 
Antigen-specific and total IgA levels in maternal milk were found to be significantly lower in 
mothers whose children developed cow's milk allergy, indicating that IgA may play a critical 
role in preventing early sensitization to food  allergens6°. 
 Sublingual immunotherapy with peanut antigens for treating peanut allergy in humans
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resulted in increased peanut-specific IgA levels in saliva, and these IgA levels were correlated 
with the degree of clinical protection61. These results support the concept that antigen-specific 
IgA is protective against primary sensitization or triggering of allergic reactions by food 
antigens.
Commensal bacteria affect he development and maintenance of oral tolerance. 
 The intestinal microbiota is beneficial for a host, as they aid in digestion, provide protection 
against pathogens, and induce and maintain immune system suitability. Conversely, the host can 
actively control the steady state composition of the microbiota by secreting antimicrobial 
peptides and immunoglobulins, which highlights the state of a highly active dynamic 
symbiosis62. The microbiota tightly controls constitutive cytokine production by lymphocytes, 
as germ-free mice exhibit considerable deficiencies in basal cytokine production63'  4.Specific 
commensals can shape the gut-associated immune system. For example, segmented filamentous 
bacteria (SFBs) and Clostridium spp. regulate the prevalence ofdistinct helper and regulatory T 
cell populations65'  6.Commensal bacteria, such as Bacteroides and  Bifidobacteria spp, can 
directly induce monocyte-derived DCs to acquire atolerogenic phenotype67. The microbiota can 
also directly contribute o the expansion ofLP resident  CX3CR1+ cells, which is associated with 
local expansion of Treg cells68. Microbiota-derived products can also control the activation
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status of liver resident DCs and increase the activation threshold required for inducing of 
immune responses69. Thus, it is conceivable that the composition ofmicrobiota might affect oral 
tolerance. 
 There are controversial reports on the capacity to induce oral tolerance in germ-free mice that 
are devoid of live intestinal  bacteria"'  71. In the absence of a microbiota, the  CD4+ T cell 
population is diminished and disproportionately affects the production of  Thl and Th17 cells, 
although Treg frequencies are maintained or increased in the small intestine63. Colonization of 
germ-free mice with complex microbiota orchestrates a broad spectrum of  Thl,  Th17 and Treg 
responses72. Oral tolerance can be restored by reconstituting erm free mice with 
 Bifidobacterium infantis, a dominant commensal bacterium or by feeding these mice with LPS73' 
74. Although LPS has been associated with the acquisition of oral tolerance, the precise 
molecular mechanisms underlying this phenomenon a d the targets of microbe-derived signals 
remains incompletely understood. Moreover, in a mouse model, feeding them with Clostridium 
leptum increased the number of Tregs in the spleens, and mediastinal lymph nodes, and 
attenuated allergen-induced airway hyperresponsiveness and inflammation by inhibiting 
inflammatory cytokine production, while enhancing  IL-10 and  TGF—(31 production in the 
lungs75. 
  After the hygiene hypothesis was first proposed, some epidemiological data suggested that
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asthma and atopic diseases were associated with childhood antibiotic use and an altered 
intestinal microbiota nd that the compositions of the intestinal microbiota differed between 
allergic and nonallergic infants76'  77.A birth cohort study that followed high-risk children from 
birth to 6 years of age demonstrated that the bacterial diversity in the intestinal microbiota was 
inversely associated with the risk of allergic sensitization to foods and aeroallergens, peripheral 
blood eosinophilia, nd allergic rhinitis78. Other studies have identified specific differences in 
the microbiota of allergic and nonallergic  childre1179'  80. 
  To date, no definitive subset of the microbiota has been identified that is associated with 
atopy, aside from limited evidence that Clostridium difficile may be overrepresented in some 
atopic  infants". This suggests that although intestinal microbial colonization is required for 
proper immune function development, certain types of microbes may play a significant role in 
skewing immune responses toward allergic sensitization, possibly by creating an environment 
that enhances the development of allergic disease.
Oral antigen sensitization and the development of food allergy
Food
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soluble whey proteins a- and  13-lactalbumin were readily transcytosed through enterocytes, 
whereas insoluble casein in micelles and heat-aggregated a- and 13-lactalbumin were 
preferentially taken up into Peyer's patches82. The delivery of food antigens into the Peyer's 
patches may have resulted in a more robust sensitization. However, if these antigens were 
unable to traffic across the villus enterocytes, they were unable to elicit anaphylactic symptoms 
upon oral challenge. These results uggest that for the development of food allergy, both antigen 
sensitization established by antigen uptake via Peyer's patches and exposure to ample amounts 
of soluble antigens that are transferred across the epithelial barrier are indispensable. 
 Human intestinal epithelial cells constitutively express the low affinity IgE receptor CD23 
and, thereby, transport IgE from both the basal-to-apical nd apical-to-basal directions83. 
Antigen—IgE complexes were preferentially transported in the apical-to-basal direction and were 
released into the basolateral media in a form that could stimulate FcERI receptor83. Therefore, it
is possible that the presence of antigen-specific IgE can increase the amounts of transported 
antigens across the epithelium.
Pulmonary dendritic cells dictate mucosal tolerance and Th2 immunity. 
 A network of  CD1111- cDCs that express  CD103, langerin, and increased lymphotactin 
receptor XCR1, is found in the epithelial layer of the conducting airways. These cells protrude
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cellular extensions between the basolateral spaces of basal epithelial cells. Immediately below 
the basement membrane, the lamina propria contains  CD1  lbhi cDCs that express  SIRPa, and 
increased levels of the fractalkine receptor  CX3CR1. The conducting airways also contain 
 CD1  1  Cdim pDCs that express Siglec-H and bone marrow stromal antigen-2 (BST2)84. 
 Lung parenchymal DCs are found in the alveolar septa. These can also be subdivided into 
 CD1  lb+ and  CM  113-cDCs, and include a subpopulation of pDCs. Some DCs, primarily 
 CX3CR1+CD1  lb+ cells, also patrol the vessel walls of the pulmonary arterial vasculature and 
can capture injected embolic  material". 
 During inflammation, additional  CD1  lb+ monocyte-derived DCs that express Ly6C and 
FcERI are recruited to the lungs. In human bronchoalveolar l vage (BAL) fluid, three types of 
DC populations have been identified;  CD  11  c+CD  1c+ myeloid (m)DC type  1,  CD  11  c+BDCA-3 
 (CD1  4  1)+ mDC type 2, and  CD1  lc  BDCA-2+ pDCs. Human  mDC1  s correspondtothe mouse 
 CD1  1b+CD1  03- cDC subset, mDC2s correspond to  CD1  1b-CD1  03+1angerin+ cDCs, andhuman 
pDCs correspond tomurine pDCs84. 
 Mouse intraepithelial lung  CD1  03+CD1  lb- cDCs and human monocyte-derived DCs form 
tight junctions with neighboring airway epithelial cells to protect he epithelial barrier function 
during the processes involved with antigen uptake, while allowing the exchange of inhaled 
particles. The transepithelial transport of inhaled antigens by  CD1  03+CD11b- cDCs is followed
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by antigen uptake by more deeply situated  CD1  lb+ cDCs. These lung DCs orchestrate he 
immune responses topathogens, commensal bacteria nd innocuous inhaled antigens85. Whether 
a specific subset of DCs presents inhaled antigens in a tolerogenic manner or induces 
Th2-biased immune responses remains unknown. 
 Pulmonary DCs survey the airways by continuously migrating from the lungs to the T cell 
paracortex of the draining mediastinal nd peribronchial lymph nodes in a CCR7-dependent 
 way86'  87. Those DCs that concomitantly acquire a semi-mature phenotypeby receiving subtle 
maturation signals, presumably from the local microbiota, are thought o induce Tregs that 
control pulmonary tolerance and homeostasis"  88-90. Quiescent pulmonary stromal cells promote 
 TGF-P-dependent differentiation f tolerogenic DCs, which promote the differentiation f Tregs 
in  vitro91. 
 Three pDCs subsets can be identified based on their expressions of  CD8a and  CDR., and 
exhibit differences in their functional capacities to prime  naïve  CD4+ T cells. CD8  cc-  p  - pDCs 
are immunogenic, whereas CD8  oc+  p- and CD8  oc+  13+ pDCs exhibit tolerogenic properties to 
support the conversion of naive  CD4+ T cells into  Foxp3+ Treg cells92. Expression of RALDH1, 
2 and 3 by tolerogenic lung pDCs and the subsequent production of RA are critical for inducing 
Treg  cells14'  92. The steady state co-existence ofcDCs with pDCs is thought to promote tolerance 
to inhaled antigens.
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  When there is concomitant exposure to innocuous antigens with inhaled environmental 
adjuvants, uch as cigarette smoke, fine particulate matter, or bacterial contaminants, lung DCs 
acquire appropriate maturation stimuli, and subsequently release cytokines and express 
costimulatory molecules that govern acquired immunity. A subset of  c-kit+  FcgRI+ DCs or 
 SIRPa+CD11b+ DCs has been shown to effectively prime Th2-biased  immunity93-96. It was 
recently shown that  CD11b+ cDCs, but not  CD103+ cDCs, were primarily responsible for 
inducing Th2 immunity in HDM-specific T cells and that monocyte-derived DCs were also 
sufficient to induce Th2 cell-mediated immunity, but only when high-dose HDM was 
administered97. Moreover, in allergen-challenged mice,  CD1  lb+ DCs were a prominent source 
of the chemokines  CCL17 and CCL22, and thereby recruited  CCR4+ Th2 cells to the lungs98'  99. 
Although any lung DCs appear to have the capacity to induce Th2 effector responses, as well as 
 Thl, or Th17 responses, depending on the type and strength of the provoking stimulus, asubset 
of DCs may play critical roles during the priming and maintenance of Th2 immunity and 
antigen sensitization.
Pulmonary epithelium initiates antigen sensitization. 
 The pulmonary epithelium provides a barrier between the external inhaled environment and 
the internal tissues. Besides providing a physical barrier, the pulmonary epithelium is
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immunologically active and is pivotal in the development of immune responses in the lung. 
Pulmonary epithelial cells can secrete a wide range of cytokines and chemokines in response to 
danger signals and, thereby, direct immune responses and recruit cells of the innate and adaptive 
immune system. 
 Epithelial cells sense microbes through pattern recognition receptors (PRRs) that include 
TLRs, NOD-like receptors, protease-activated receptors (PARs), and C-type lectin receptors, 
which recognize pathogen-associated molecular patterns from viruses, bacteria, fungi, and 
multicellular  parasites  1°°. Although PRR-triggered immune responses provide a critical 
antimicrobial monitoring system, it is now clear that many allergens have the potential to 
modify the epithelial barrier through PRRs. CD23 ligation can activate pro-inflammatory 
pathways in human intestinal epithelial cells and result in the release of chemokines, including 
 CCL201°1. 
 Bronchial epithelial cells first attract immature DCs or their precursors through their release 
of CCL2 or  CCL20 chemokines and subsequently instruct them to induce Th2 immunity to 
allergens via the release of innate pro-Th2 cytokines, such as GM-CSF, thymic stromal 
lymphopoietin (TSLP), and IL-25 and  -33102,  103. IL-33 and TSLP can drive allergic 
inflammation, even in the absence of IL-4, and promote Th2 cell differentiation by 
programming the function of  DCs104-106. IL-25 exacerbates airway hyperreactivity in the absence
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of Th2  cytokinesl°7. 
 House dust mite antigen triggers epithelial cells to produce  IL-la in a TLR4-dependent 
 manner108. The  IL-la subsequently acts in an autocrine manner on the lung epithelial cells, 
which results in their secretion of proinflammatory chemokines, GM-CSF, and IL-33. Together, 
these mediators recruit and activate inflammatory DCs that induce adaptive Th2 immunity to 
this antigen. TSLP becames important only when high doses of antigen are administered. 
Application of mucosal immunity to immunotherapy for allergic diseases. 
Mucosal immunotherapy is more advantageous compared with subcutaneous immunotherapy 
from a production and regulatory perspective; antigens that are used for mucosal 
immunotherapy do not require extensive purification to remove bacterial contaminants, as the 
mucosal surface is already colonized by bacteria. The procedure for antigen administration is 
relatively easy. Under normal conditions, however, after their ingestion, proteins or 
carbohydrates are exposed to changing pH levels and digestive enzymes during gastrointestinal 
transit, resulting in antigen  degradation1°9. 
The capacity of transcytosis through the intestinal epithelial layer depends on particle size; a 
particle size < 1  !um is optimal for M-cell  absorptionm. Transcytosis also depends on the charge 
and hydrophilicity of the particle carrier. Once bound to the apical side of M cells,
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macromolecules are endocytosed via clathrin-coated vesicles, and thereby reach the lysosomal 
compartment, from which they are exocytosed to a basolateral site to be taken up by DCs. To 
overcome the degrading conditions in the gastrointestinal tract, encapsulating antigens into 
particle carriers, such as liposomes may enable intact antigens to reach the intestinal epithelial 
 layer". Furthermore, modifying particles by special targeting materials can direct particle 
binding to specific cells and enhance the particle uptake capacity via intestinal cells and DCs. 
 Several studies have demonstrated that mannosylated-liposomes could enhanceboth Ag 
presentation and T cell stimulation by targeting mannose receptors on  APCS112-114. The 
combination of a dimannosyl ligand for liposomal vesicle targeting and Toll-like receptor 
(TLR)-2 ligand Pam2CAG for immune stimulation promoted binding to APCs and stimulating 
cellular immune  responses115. Subcutaneous or intraperitoneal delivery of oligomannose-coated 
liposomes induced only systemic immune responses, whereas intranasal delivery induced 
mucosal immunity as well as systemic  immunity116. Therefore, the modifications used for 
antigen particle carriers and the route of administration are important determinants for the 
effects of immunotherapy. 
 Zhou et al. reported that sugar modified antigen binding to the innate immune receptor 
 SIGN-R1 (murine homolog of human DC-SIGN) could reduce the anaphylactic response to 
food allergen by inducing DCs to release  IL-10 and to generate  Trl  cells117. Based on their
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findings, we have demonstrated that intranasal immunization with Ag encased in oligomannose 
coated liposomes may be an effective immunotherapy for food allergies, as it induced a subset 
of regulatory  CD8+ T cells as well as  CD4+CD25+Foxp3+ T cells and modulated humoral 
immune responses, even in allergen-sensitized  micelle
Conclusion 
 We have focused primarily on DCs and various regulatory cells that may participate in the 
induction of oral tolerance and the mechanisms that have been elucidated primarily in animal 
models. Understanding the mechanisms involved in oral tolerance is crucial for the development 
of novel therapeutic strategies to prevent or reverse hypersensitivity reactions to foods and 
aeroantigens.
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Figure Legends 
Figure 1. Roles of dendritic cells and mesenteric lymph nodes in oral tolerance 
 CX3CR1+ cDCs sample antigens by extending dendrites.  CD103+DCs capture antigens that are 
transported by paracellular diffusion across enterocytes, either by M cell-mediated transcytosis, 
or by goblet-cell-associated antigen passage. Antigen-loaded  CD103+ cDCs migrate to the 
mesenteric lymph nodes and then induce the differentiation of iTregs.  CX3CR1+ cells produce 
 IL-10 and facilitate the expansion of iTregs in the lamina propria. Antigen transported into the 
lamina propria may reach the liver via portal vein. Kupffer cells, cDCs, and sinusoidal 
endothelial cells act as non-professional antigen-presenting cells to induce tolerance.
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